4.5 Article

Regulation of membrane band 3 Tyr-phosphorylation by proteolysis of p72Syk and possible involvement in senescence process

Journal

ACTA BIOCHIMICA ET BIOPHYSICA SINICA
Volume 41, Issue 10, Pages 846-851

Publisher

OXFORD UNIV PRESS
DOI: 10.1093/abbs/gmp071

Keywords

band 3 Tyr-phosphorylation; Syk; proteolysis; human erythrocyte

Funding

  1. Italian Ministero dell'Universita e della Ricerca Scientifica e Tecnologica (MURST)

Ask authors/readers for more resources

Erythrocyte senescence is characterized by exposure of cell surface epitopes on cell membrane proteins leading to immune mediated removal of red blood cells. One mechanism for antigen formation is tyrosine phosphorylation (Tyr-P) of the transmembrane protein band 3 by Syk kinase. Our aim was to test the hypothesis that proteolytic activation of Syk kinase by conversion from 72 kDa (p72(Syk)) to the 36 kDa (p36(Syk)) isoform enhances its phosphorylating activity independently of the association of Syk kinase with the cytoskeleton. Tyr-P assay was conducted using quantification of P-32 uptake into the cytoplasmic domain of band 3 after addition of p72(Syk) or p36(Syk). Effect of pre-phosphorylation of erythrocyte membrane band 3 protein by p36(Syk) on p72(Syk)-mediated phosphorylation and the effect of addition of a protease inhibitor (leupeptin) on p72(Syk)-mediated phosphorylation were studied by autoradiographic visualization of P-32 uptake. Tyr-P by Syk isoforms of membrane skeletal and soluble fractions of band 3 was visualized by immunoblotting. It was found that p36(Syk) had a higher band 3 tyrosine phosphorylating activity compared with p72(Syk). Pre-phosphorylation with p36(Syk) or p72(Syk) increased band 3 phosphorylating activity. Protease inhibition treatment reduced p72(Syk) but not p36(Syk) band 3 tyrosine phosphorylating activity significantly. Both soluble and membrane skeletal fractions of band 3 protein were equally tyrosine phosphorylated by each Syk isoform. In conclusion, we confirmed the hypothesis that proteolytic cleavage of p72(Syk) is an important regulatory step for band 3 Tyr-P and its independence of the association of band 3 with the cytoskeleton.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Review Obstetrics & Gynecology

Hyaluronic acid in vulvar and vaginal administration: evidence from a literature systematic review

G. Buzzaccarini, L. Marin, M. Noventa, A. Vitagliano, A. Riva, F. Dessole, G. Capobianco, L. Bordin, A. Andrisani, G. Ambrosini

Summary: This study conducted a systematic review on the effects of hyaluronic acid in improving vulvovaginal pathology symptoms, finding hyaluronic acid generally effective as a moisturizer for women who cannot undergo estrogen therapy due to contraindications or are experiencing symptoms affecting sexual well-being. Further well-designed randomized controlled trials are needed to confirm its efficacy.

CLIMACTERIC (2021)

Article Biochemistry & Molecular Biology

Endometriosis Susceptibility to Dapsone-Hydroxylamine-Induced Alterations Can Be Prevented by Licorice Intake: In Vivo and In Vitro Study

Chiara Sabbadin, Alessandra Andrisani, Gabriella Dona, Elena Tibaldi, Anna Maria Brunati, Stefano Dall'Acqua, Eugenio Ragazzi, Guido Ambrosini, Decio Armanini, Luciana Bordin

Summary: This study found that licorice intake can decrease oxidative damage to RBCs caused by DDS-NHOH, and this reduction is directly related to plasma GA concentration. Therefore, GA may be considered a new potential tool for preventing severe endometriosis.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)

Editorial Material Peripheral Vascular Disease

Idiopathic inflammatory myopathies and hypertension: Possible involvement of hormonal factors

Decio Armanini, Chiara Sabbadin, Luciana Bordin

JOURNAL OF CLINICAL HYPERTENSION (2021)

Letter Andrology

A suggestion to overcome potential risks for infertility due to COVID-19: A response to Aitken

Loris Marin, Guido Ambrosini, Ludovica Nuzzi, Luciana Bordin, Alessandra Andrisani

ANDROLOGY (2022)

Editorial Material Peripheral Vascular Disease

Unilateral primary aldosteronism considerations about the diagnostic criteria, adrenalectomy, and short and long time biochemical and clinical evaluation

Decio Armanini, Marco Boscaro, Chiara Sabbadin, Luciana Bordin

JOURNAL OF CLINICAL HYPERTENSION (2022)

Article Oncology

Targeting of HSP70/HSF1 Axis Abrogates In Vitro Ibrutinib-Resistance in Chronic Lymphocytic Leukemia

Federica Frezzato, Andrea Visentin, Filippo Severin, Serena Pizzo, Edoardo Ruggeri, Nayla Mouawad, Leonardo Martinello, Elisa Pagnin, Valentina Trimarco, Alessia Tonini, Samuela Carraro, Stefano Pravato, Silvia Imbergamo, Sabrina Manni, Francesco Piazza, Anna Maria Brunati, Monica Facco, Livio Trentin

Summary: The use of ibrutinib has significantly changed the management of chronic lymphocytic leukemia (CLL) patients, but resistance to treatment can occur. High levels of HSP70 and its regulator HSF1 have been found in patients experiencing ibrutinib failure, suggesting their involvement in drug resistance mechanisms. Inhibitors targeting the HSP70/HSF1 axis may be a novel therapeutic strategy to overcome ibrutinib resistance in CLL patients.

CANCERS (2021)

Article Biochemistry & Molecular Biology

The mitochondrial chaperone TRAP1 regulates F-ATP synthase channel formation

Giuseppe Cannino, Andrea Urbani, Marco Gaspari, Mariaconcetta Varano, Alessandro Negro, Antonio Filippi, Francesco Ciscato, Ionica Masgras, Christoph Gerle, Elena Tibaldi, Anna Maria Brunati, Giorgio Colombo, Giovanna Lippe, Paolo Bernardi, Andrea Rasola

Summary: This study reveals that the mitochondrial chaperone TRAP1 interacts with F-ATP synthase, increasing its catalytic activity and counteracting the inhibitory effect of CyPD. Additionally, TRAP1 directly inhibits the channel activity of F-ATP synthase and reverses PTP induction by CyPD, thus preventing mitochondrial depolarization and cell death. These findings highlight the importance of TRAP1 in cell bioenergetics and survival.

CELL DEATH AND DIFFERENTIATION (2022)

Letter Endocrinology & Metabolism

Can the treatment of polycystic ovary syndrome with spironolactone prevent severe COVID infection?

Decio Armanini, Chiara Sabbadin, Luigi De Marco, Luciana Bordin

Summary: A recent study found that women with polycystic ovary syndrome (PCOS) have a 52% increased risk of COVID-19 infection, with nearly twice the incidence compared to women without PCOS. A survey of 200 unvaccinated women with PCOS who had been treated with spironolactone for more than 4 months revealed only four infected patients, with mild or minimal symptoms. Further research is needed to confirm these findings and evaluate the use of spironolactone in both PCOS and the general population for COVID-19.

EUROPEAN JOURNAL OF ENDOCRINOLOGY (2022)

Review Biochemistry & Molecular Biology

Controversies in the Pathogenesis, Diagnosis and Treatment of PCOS: Focus on Insulin Resistance, Inflammation, and Hyperandrogenism

Decio Armanini, Marco Boscaro, Luciana Bordin, Chiara Sabbadin

Summary: PCOS is a heterogeneous and common disease with symptoms varying with age, typically characterized by hyperandrogenism, chronic oligo-anovulation, and metabolic disorders. Treatment involves lifestyle improvements and medications tailored to individual cases.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2022)

Article Endocrinology & Metabolism

Long-Lasting Effects of Spironolactone after its Withdrawal in Patients with Hyperandrogenic Skin Disorders

Chiara Sabbadin, Francesca Beggiao, Carlotta Keiko Vedolin, Gloria Orlando, Eugenio Ragazzi, Filippo Ceccato, Mattia Barbot, Luciana Bordin, Gabriella Dona, Alessandra Andrisani, Anna Belloni Fortina, Carla Scaroni, Decio Armanini

Summary: This study demonstrates that spironolactone is a safe and effective treatment for hyperandrogenic skin disorders, particularly in patients with polycystic ovary syndrome. The medication can provide long-lasting improvement in symptoms, even after discontinuation for several months.

ENDOCRINE METABOLIC & IMMUNE DISORDERS-DRUG TARGETS (2023)

Editorial Material Peripheral Vascular Disease

Pitfalls in website information on dietary sodium restriction

Decio Armanini, Luciana Bordin, Jacopo Manso, Marco Boscaro, Chiara Sabbadin

JOURNAL OF CLINICAL HYPERTENSION (2022)

Review Oncology

Protein Phosphorylation and Redox Status: An as Yet Elusive Dyad in Chronic Lymphocytic Leukemia

Mario Angelo Pagano, Federica Frezzato, Andrea Visentin, Livio Trentin, Anna Maria Brunati

Summary: Phosphorylation is a crucial modification that regulates cellular functions, and its dysregulation is observed in chronic lymphocytic leukemia (CLL). Reactive oxygen species (ROS) and phosphorylation cooperate to support the survival of CLL cells. ROS and phosphorylation mainly influence the balance between redox homeostasis and transcription factors.

CANCERS (2022)

Meeting Abstract Psychiatry

Mitochondrial ATP production is impaired in neural stem/progenitor cells derived from olfactory neuroepithelium of patients with schizophrenia

C. Idotta, E. Tibaldi, N. Favaretto, M. Pagano, R. Peruzzo, G. Pigato, D. Cazzador, P. Meneguzzo, M. Solmi, L. Leanza, A. Favaro, A. M. Brunati, T. Toffanin

EUROPEAN PSYCHIATRY (2021)

Meeting Abstract Obstetrics & Gynecology

Thyroid function in euthyroid women during controlled ovarian stimulation (COH): does the TSH fluctuations have an impact on IVF outcomes?

M. Noventa, A. Riva, G. Buzzaccarini, L. Marin, C. Sabbadin, L. Bordin, M. Menegazzo, G. Ambrosini, A. Andrisani

HUMAN REPRODUCTION (2021)

No Data Available